|
Sekisui Chemical Co., Ltd. (4204.t) DCF -Bewertung |
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Sekisui Chemical Co., Ltd. (4204.T) Bundle
Gewinnen Sie die Meisterschaft über Ihre Sekisui Chemical Co., Ltd. (4204T) Bewertungsanalyse unter Verwendung unseres hochmodernen DCF-Taschenrechners! Diese Excel -Vorlage wird mit realen Daten für (4204T) vorinstalliert, sodass Sie Prognosen und Annahmen anpassen können, um den inneren Wert von Sekisui Chemical Co., Ltd. genau zu bestimmen.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,129,254.0 | 1,056,560.0 | 1,157,945.0 | 1,242,521.0 | 1,256,538.0 | 1,292,947.8 | 1,330,412.5 | 1,368,962.9 | 1,408,630.3 | 1,449,447.1 |
| Revenue Growth, % | 0 | -6.44 | 9.6 | 7.3 | 1.13 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 |
| EBITDA | 129,740.0 | 116,647.0 | 137,584.0 | 150,798.0 | 165,252.0 | 154,374.9 | 158,848.1 | 163,451.0 | 168,187.2 | 173,060.6 |
| EBITDA, % | 11.49 | 11.04 | 11.88 | 12.14 | 13.15 | 11.94 | 11.94 | 11.94 | 11.94 | 11.94 |
| Depreciation | 45,256.0 | 49,345.0 | 48,704.0 | 50,432.0 | 52,672.0 | 54,652.1 | 56,235.7 | 57,865.2 | 59,542.0 | 61,267.3 |
| Depreciation, % | 4.01 | 4.67 | 4.21 | 4.06 | 4.19 | 4.23 | 4.23 | 4.23 | 4.23 | 4.23 |
| EBIT | 84,484.0 | 67,302.0 | 88,880.0 | 100,366.0 | 112,580.0 | 99,722.8 | 102,612.4 | 105,585.7 | 108,645.2 | 111,793.3 |
| EBIT, % | 7.48 | 6.37 | 7.68 | 8.08 | 8.96 | 7.71 | 7.71 | 7.71 | 7.71 | 7.71 |
| Total Cash | 76,819.0 | 87,454.0 | 144,534.0 | 101,080.0 | 138,572.0 | 120,825.9 | 124,327.0 | 127,929.5 | 131,636.4 | 135,450.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 172,747.0 | 169,459.0 | 184,490.0 | 190,815.0 | 211,197.0 | 205,407.1 | 211,359.1 | 217,483.5 | 223,785.3 | 230,269.8 |
| Account Receivables, % | 15.3 | 16.04 | 15.93 | 15.36 | 16.81 | 15.89 | 15.89 | 15.89 | 15.89 | 15.89 |
| Inventories | 217,189.0 | 222,909.0 | 243,837.0 | 286,799.0 | 298,232.0 | 279,806.2 | 287,913.9 | 296,256.6 | 304,841.0 | 313,674.2 |
| Inventories, % | 19.23 | 21.1 | 21.06 | 23.08 | 23.73 | 21.64 | 21.64 | 21.64 | 21.64 | 21.64 |
| Accounts Payable | 104,916.0 | 92,542.0 | 109,846.0 | 107,826.0 | 123,858.0 | 119,134.6 | 122,586.6 | 126,138.7 | 129,793.8 | 133,554.7 |
| Accounts Payable, % | 9.29 | 8.76 | 9.49 | 8.68 | 9.86 | 9.21 | 9.21 | 9.21 | 9.21 | 9.21 |
| Capital Expenditure | -57,227.0 | -62,067.0 | -44,614.0 | -56,407.0 | -60,455.0 | -62,438.9 | -64,248.1 | -66,109.8 | -68,025.4 | -69,996.5 |
| Capital Expenditure, % | -5.07 | -5.87 | -3.85 | -4.54 | -4.81 | -4.83 | -4.83 | -4.83 | -4.83 | -4.83 |
| Tax Rate, % | 30.09 | 30.09 | 30.09 | 30.09 | 30.09 | 30.09 | 30.09 | 30.09 | 30.09 | 30.09 |
| EBITAT | 59,820.4 | 44,255.1 | 47,159.5 | 69,870.0 | 78,699.7 | 65,646.2 | 67,548.4 | 69,505.7 | 71,519.7 | 73,592.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -237,170.6 | 16,727.1 | 32,594.5 | 12,588.0 | 55,133.7 | 77,351.6 | 48,928.4 | 50,346.2 | 51,805.0 | 53,306.1 |
| WACC, % | 5.61 | 5.59 | 5.54 | 5.61 | 5.61 | 5.59 | 5.59 | 5.59 | 5.59 | 5.59 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 242,189.7 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 54,372 | |||||||||
| Terminal Value | 1,514,138 | |||||||||
| Present Terminal Value | 1,153,538 | |||||||||
| Enterprise Value | 1,395,727 | |||||||||
| Net Debt | -17,849 | |||||||||
| Equity Value | 1,413,576 | |||||||||
| Diluted Shares Outstanding, MM | 425 | |||||||||
| Equity Value Per Share | 3,328.20 |
What You Will Receive
- Pre-Filled Financial Model: Sekisui Chemical’s actual data allows for accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential variables.
- Instantaneous Calculations: Automatic updates ensure immediate visibility of results with each adjustment.
- Professional-Grade Template: A polished Excel file crafted for high-caliber valuation.
- Customizable and Reusable: Designed for adaptability, facilitating repeated use for comprehensive forecasts.
Key Features of Sekisui Chemical Co., Ltd. (4204T)
- Customizable Forecast Inputs: Adjust essential factors such as revenue growth, EBITDA %, and capital expenditures to suit your analysis.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and additional metrics for immediate insights.
- High-Precision Results: Leverages Sekisui's actual financial data for accurate and reliable valuation outputs.
- Simplified Scenario Analysis: Effortlessly test various assumptions and evaluate different outcomes.
- Efficiency Booster: Streamline your workflow by avoiding the creation of intricate valuation models from the ground up.
How It Functions
- 1. Access the Template: Download and open the Excel file containing Sekisui Chemical Co., Ltd.'s preloaded data.
- 2. Modify Assumptions: Adjust critical inputs such as growth rates, WACC, and capital expenditures.
- 3. Instantly View Results: The DCF model automatically computes intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
- 5. Utilize with Assurance: Present professional valuation insights to bolster your decision-making.
Why Opt for Sekisui Chemical Co., Ltd. (4204T) Calculator?
- Precision: Utilizes authentic Sekisui financial data for reliable results.
- Versatility: Built to allow users to easily experiment with and adjust inputs.
- Efficiency: Avoid the complexities of creating a financial model from the ground up.
- Expert-Quality: Crafted with the accuracy and functionality expected at the CFO level.
- Accessible: Designed for ease of use, making it suitable for users without advanced financial modeling skills.
Who Can Benefit from Sekisui Chemical Co., Ltd. (4204T)?
- Investors: Gain confidence in your investment choices with our expert-grade valuation tools.
- Financial Analysts: Streamline your workflow with a customizable pre-built DCF model.
- Consultants: Quickly tailor the template for impactful client presentations or detailed reports.
- Finance Enthusiasts: Enhance your grasp of valuation methods through practical, real-world examples.
- Educators and Students: Utilize it as an effective educational resource in finance courses.
Contents of the Template
- Preloaded 4204T Data: Historical and projected financial information, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Expert-level spreadsheets designed for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for modifying revenue growth, tax rates, and discount rates.
- Financial Statements: Detailed annual and quarterly financial reports for thorough analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to assess performance.
- Dashboard and Charts: Visual representations of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.